Susquehanna International Group
RARE icon

Susquehanna International Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Susquehanna International Group’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.11M Sell
243,900
-253,200
-51% -$5.7M ﹤0.01% 4178
2025
Q4 		$11.4M Buy
497,100
+201,500
+68% +$6.63M ﹤0.01% 2888
2025
Q3 		$8.89M Sell
295,600
-209,900
-42% -$6.29M ﹤0.01% 3186
2025
Q2 		$18.4M Buy
505,500
+394,800
+357% +$14.2M ﹤0.01% 2100
2025
Q1 		$4.01M Buy
110,700
+5,800
+6% +$241K ﹤0.01% 4071
2024
Q4 		$4.41M Sell
104,900
-89,500
-46% -$4.44M ﹤0.01% 3801
2024
Q3 		$10.8M Buy
194,400
+28,900
+17% +$1.47M ﹤0.01% 2516
2024
Q2 		$6.8M Buy
165,500
+33,600
+25% +$1.43M ﹤0.01% 2969
2024
Q1 		$6.16M Buy
131,900
+20,400
+18% +$962K ﹤0.01% 3302
2023
Q4 		$5.33M Sell
111,500
-121,900
-52% -$4.73M ﹤0.01% 3599
2023
Q3 		$8.32M Buy
233,400
+137,700
+144% +$5.46M ﹤0.01% 2791
2023
Q2 		$4.41M Buy
95,700
+18,300
+24% +$849K ﹤0.01% 3736
2023
Q1 		$3.1M Sell
77,400
-54,500
-41% -$2.34M ﹤0.01% 4265
2022
Q4 		$6.11M Buy
131,900
+38,500
+41% +$1.51M ﹤0.01% 2930
2022
Q3 		$3.87M Buy
93,400
+71,700
+330% +$3.68M ﹤0.01% 3577
2022
Q2 		$1.29M Buy
21,700
+17,000
+362% +$1.05M ﹤0.01% 5891
2022
Q1 		$341K Buy
4,700
+2,300
+96% +$160K ﹤0.01% 9961
2021
Q4 		$202K Sell
2,400
-9,000
-79% -$732K ﹤0.01% 11430
2021
Q3 		$1.03M Sell
11,400
-21,200
-65% -$1.92M ﹤0.01% 7485
2021
Q2 		$3.11M Sell
32,600
-53,600
-62% -$5.58M ﹤0.01% 4944
2021
Q1 		$9.81M Sell
86,200
-59,400
-41% -$8.09M ﹤0.01% 2792
2020
Q4 		$20.2M Buy
145,600
+131,200
+911% +$15.6M ﹤0.01% 1732
2020
Q3 		$1.18M Sell
14,400
-50,500
-78% -$4.19M ﹤0.01% 5710
2020
Q2 		$5.08M Buy
64,900
+12,700
+24% +$841K ﹤0.01% 2994
2020
Q1 		$2.32M Buy
52,200
+46,100
+756% +$2.39M ﹤0.01% 3711
2019
Q4 		$261K Buy
6,100
+100
+2% +$4.13K ﹤0.01% 8276
2019
Q3 		$257K Sell
6,000
-123,200
-95% -$6.69M ﹤0.01% 8635
2019
Q2 		$8.2M Buy
129,200
+6,600
+5% +$420K ﹤0.01% 2104
2019
Q1 		$8.5M Buy
122,600
+94,900
+343% +$5.42M ﹤0.01% 1895
2018
Q4 		$1.2M Sell
27,700
-120,000
-81% -$6.56M ﹤0.01% 4333
2018
Q3 		$11.3M Buy
147,700
+37,100
+34% +$3.02M ﹤0.01% 1808
2018
Q2 		$8.5M Buy
110,600
+91,300
+473% +$5.9M ﹤0.01% 2108
2018
Q1 		$984K Sell
19,300
-14,400
-43% -$725K ﹤0.01% 5271
2017
Q4 		$1.56M Sell
33,700
-47,100
-58% -$2.31M ﹤0.01% 4375
2017
Q3 		$4.3M Buy
80,800
+4,700
+6% +$278K ﹤0.01% 2694
2017
Q2 		$4.73M Sell
76,100
-25,000
-25% -$1.51M ﹤0.01% 2482
2017
Q1 		$6.85M Buy
101,100
+40,800
+68% +$3.11M ﹤0.01% 2006
2016
Q4 		$4.24M Sell
60,300
-14,900
-20% -$1.06M ﹤0.01% 2685
2016
Q3 		$5.33M Buy
75,200
+5,800
+8% +$370K ﹤0.01% 2161
2016
Q2 		$3.39M Buy
69,400
+13,500
+24% +$873K ﹤0.01% 2745
2016
Q1 		$3.54M Buy
55,900
+20,000
+56% +$1.31M ﹤0.01% 2794
2015
Q4 		$4.03M Buy
35,900
+13,700
+62% +$1.37M ﹤0.01% 2826
2015
Q3 		$2.14M Sell
22,200
-2,400
-10% -$275K ﹤0.01% 4144
2015
Q2 		$2.52M Buy
24,600
+10,700
+77% +$831K ﹤0.01% 4208
2015
Q1 		$863K Buy
13,900
+7,700
+124% +$428K ﹤0.01% 6053
2014
Q4 		$272K Sell
6,200
-37,400
-86% -$1.71M ﹤0.01% 8292
2014
Q3 		$2.47M Buy
43,600
+37,100
+571% +$1.87M ﹤0.01% 4240
2014
Q2 		$292K Buy
+6,500
New +$268K ﹤0.01% 8424

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Susquehanna International Group's RARE Position: Q1 2026 in Review

Susquehanna International Group increased its Ultragenyx Pharmaceutical (RARE) stake by 245% in Q1 2026, buying an estimated $8.39M and bringing the position to 524,798 shares worth $11M. The position accounts for ﹤0.01% of the portfolio, ranked #2979.

Susquehanna International Group first reported a position in RARE in Q2 2014 and has held it in 39 quarters since. 296 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Susquehanna International Group held 524,798 shares of Ultragenyx Pharmaceutical worth $11M as of Q1 2026.
  • Susquehanna International Group bought 372,482 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $8.39M.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2979 holding.
  • Susquehanna International Group first reported a position in Ultragenyx Pharmaceutical in Q2 2014 and has held it in 39 quarters since.
  • 296 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.